Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» psychedelic drugs
psychedelic drugs
Compass veers off course, delaying phase 3 psychedelic data and laying off 30% of staff
Fierce Biotech
Thu, 10/31/24 - 09:18 am
COMPASS Pathways
clinical trials
psychedelic drugs
depression
FDA panel votes against MDMA therapy for PTSD, citing muddy data and safety concerns
BioPharma Dive
Tue, 06/4/24 - 11:36 pm
Lykos Therapeutics
FDA
MDMA
psychedelic drugs
FDA panel to review psychedelic drug MDMA for first time
Reuters
Tue, 06/4/24 - 11:40 am
FDA
MDMA
PTSD
psychedelic drugs
Lykos Therapeutics
FDA advisers to weigh first psychedelic therapy in early June
Fierce Biotech
Tue, 05/7/24 - 11:23 am
Lykos Therapeutics
FDA
MDMA
Lykos
psychedelic drugs
advisory committees
Compass shows safety in first psilocybin trial for PTSD, but efficacy data still to come
Fierce Biotech
Wed, 12/20/23 - 09:30 am
Compass Therapeutics
clinical trials
psychedelic drugs
PTSD
psilocybin
MDMA approval filing nears after drug hits again in phase 3, showing consistent PTSD improvements
Fierce Biotech
Fri, 09/15/23 - 11:43 am
MDMA
MAPS Public Benefit Corp
clinical trials
PTSD
psychedelic drugs
A bill in Congress would fund a clinical trial studying psychedelic drugs’ effects in veterans
Houston Public Media
Thu, 08/3/23 - 10:20 am
clinical trials
Texas
psychedelic drugs
veterans
PTSD
Sanofi Strikes Deal With Mysterious Psychedelics Biotech Terran
BioSpace
Thu, 04/21/22 - 11:27 pm
Sanofi
Terran Biosciences
CNS
psychedelic drugs
Psychedelics biotech set to go public via SPAC — pushing IV form of psilocybin into PhI
Endpoints
Thu, 01/20/22 - 10:58 am
Eleusis
SPAC
psychedelic drugs
Largest psilocybin trial finds the psychedelic is effective in treating serious depression
Stat
Tue, 11/9/21 - 11:37 pm
psychedelic drugs
psilocybin
treatment-resistant depression
COMPASS Pathways
clinical trials
A new psychedelics player emerges to treat mental health disorders — minus the hallucinogenic effects
Endpoints
Mon, 09/27/21 - 10:52 am
Delix Therapeutics
psychedelic drugs
funding
mental health
Peter Thiel-backed ATAI launches new Salvia-focused biotech
Endpoints
Thu, 08/12/21 - 11:21 am
ATAI Life Sciences
Peter Thiel
psychedelic drugs
Salvia
First-of-its-kind study pits psilocybin against a common antidepressant
Stat
Wed, 04/14/21 - 09:45 pm
psilocybin
psychedelic drugs
depression
antidepressants
LSD biotech MindMed buys digital trial firm HealthMode
Pharmaforum
Fri, 02/19/21 - 10:25 am
MindMed
M&A
HealthMode
digital therapeutics
psychedelic drugs
MindMed aims for Nasdaq listing after Compass’ magic mushroom-fuelled IPO
Pharmaforum
Tue, 09/22/20 - 12:13 pm
COMPASS Pathways
IPOs
Mind Medicine
psychedelic drugs
magic mushrooms
IntelGenx inks double deals to develop oral film psychedelics for psychiatric use
Fierce Pharma
Wed, 09/16/20 - 10:34 am
drug delivery
IntelGenx
psychedelic drugs
VersaFilm
First-Of-Its-Kind Clinical Trial To Study Psychedelic Treatments For PTSD In Veterans
Forbes
Wed, 08/12/20 - 11:49 pm
psychedelic drugs
clinical trials
PTSD
NeuroPharm
Mydecine Innovations
veterans
New $17M Johns Hopkins research center to study psychedelic drugs in Alzheimer's, addiction and more
Fierce Biotech
Sat, 09/7/19 - 06:28 pm
psychedelic drugs
Johns Hopkins
drug development
Alzheimer's disease
addiction